These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3580843)

  • 1. Loss of pirenzepine regional selectivity following solubilization and partial purification of the putative M1 and M2 muscarinic receptor subtypes.
    Baumgold J; Merril C; Gershon ES
    Brain Res; 1987 Apr; 388(1):7-14. PubMed ID: 3580843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
    Wang JX; Mei L; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of verapamil on the binding characteristics of muscarinic receptor subtypes.
    Baumgold J
    Eur J Pharmacol; 1986 Jul; 126(1-2):151-4. PubMed ID: 3758159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
    Baron B; Gavish M; Sokolovsky M
    Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
    Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
    Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart.
    Mei L; Wang JX; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):991-1000. PubMed ID: 3656121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of muscarinic receptor subtypes from baculovirus infected Sf9 insect cells.
    Rinken A; Kameyama K; Haga T; Engström L
    Biochem Pharmacol; 1994 Sep; 48(6):1245-51. PubMed ID: 7945418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.
    Vanderheyden P; Ebinger G; Dierckx R; Vauquelin G
    J Neurol Sci; 1987 Dec; 82(1-3):257-69. PubMed ID: 3440867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
    Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of pirenzepine to digitonin-solubilized muscarinic acetylcholine receptors from the rat myocardium.
    Birdsall NJ; Hulme EC; Keen M
    Br J Pharmacol; 1986 Feb; 87(2):307-16. PubMed ID: 3754173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of muscarinic cholinergic receptor subtypes in human cortex and pons: implications for anti-motion sickness therapy.
    McCarthy BG; Peroutka SJ
    Aviat Space Environ Med; 1988 Jan; 59(1):63-6. PubMed ID: 3355470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential coupling between muscarinic receptors and G-proteins in regions of the rat brain.
    Ghodsi-Hovsepian S; Messer WS; Hoss W
    Biochem Pharmacol; 1990 Apr; 39(8):1385-91. PubMed ID: 2108689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.